Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065165 | SCV001230112 | pathogenic | Catecholaminergic polymorphic ventricular tachycardia | 2019-01-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln245*) in the CASQ2 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs754834466, ExAC 0.01%). This variant has not been reported in the literature in individuals with CASQ2-related conditions. Loss-of-function variants in CASQ2 are known to be pathogenic (PMID: 12386154). For these reasons, this variant has been classified as Pathogenic. |